お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
326153

腎結石:世界の治験動向

Renal Stones/Calculi Global Clinical Trials Review, H2, 2019

出版日: | 発行: GlobalData | ページ情報: 英文 225 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.78円
腎結石:世界の治験動向
出版日: 2019年12月19日
発行: GlobalData
ページ情報: 英文 225 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、腎結石に関する臨床研究の最新動向について調査し、地域・進捗状況・フェーズ (相) ・募集状況別の実施件数や、代表的なスポンサー、開発中の治療薬の情報、世界各国の主要企業・機関での進行状況、有望な薬剤の比較といった情報を盛り込んでお届けします。

イントロダクション

  • 腎結石
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:泌尿生殖器系および性ホルモン関連の治験における腎結石の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:泌尿生殖器系および性ホルモン関連の治験における腎結石の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

腎結石治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • アステラス製薬
    • The Himalaya Drug Company
    • Omeros Corporation
    • Allena Pharmaceuticals, Inc.
    • Indus Biotech Private Limited
    • Hamad Medical Corporation
    • Catalysis, S.L.
    • Actavis plc
  • 代表的な研究機関・病院の治験の概要
    • University Hospital Inselspital, Berne
    • Shahid Beheshti University
    • Mayo Clinic
    • Fredericia Hosptial
    • St. Michael's Hospital
    • University of Minnesota
    • Hadassah Medical Organization
    • Emory University
    • University of Zurich
    • University of British Columbia

5つの代表的な治験のプロファイル

付録

図表

List of Tables

  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Region, 2019* 8
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Renal Stones/Calculi Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
  • Renal Stones/Calculi Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
  • Renal Stones/Calculi Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
  • Renal Stones/Calculi Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
  • Renal Stones/Calculi Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 18
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 21
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 23
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 26
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Phase, 2019* 27
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Trial Status, 2019* 30
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
  • Renal Stones/Calculi Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

List of Figures

  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
  • Renal Stones/Calculi Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
  • Renal Stones/Calculi Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
  • Renal Stones/Calculi Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
  • Renal Stones/Calculi Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
  • Renal Stones/Calculi Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 17
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
  • Renal Stones/Calculi Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
  • Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 22
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24
  • Renal Stones/Calculi Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28
  • Renal Stones/Calculi Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
  • Renal Stones/Calculi Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
  • Renal Stones/Calculi Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38
  • GlobalData Methodology 228
目次
Product Code: GDHC5214CTIDB

GlobalData's clinical trial report, "Renal Stones/Calculi Global Clinical Trials Review, H2, 2019" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Stones/Calculi. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 19
  • Clinical Trials in G7 Countries by Trial Status 20
  • Clinical Trials by E7 Countries: Proportion of Renal Stones/Calculi to Genito Urinary System And Sex Hormones Clinical Trials 22
  • Clinical Trials by Phase in E7 Countries 24
  • Clinical Trials in E7 Countries by Trial Status 25
  • Clinical Trials by Phase 27
  • In Progress Trials by Phase 28
  • Clinical Trials by Trial Status 29
  • Clinical Trials by End Point Status 31
  • Subjects Recruited Over a Period of Time 32
  • Clinical Trials by Sponsor Type 33
  • Prominent Sponsors 34
  • Top Companies Participating in Renal Stones/Calculi Therapeutics Clinical Trials 36
  • Prominent Drugs 38
  • Clinical Trial Profile Snapshots 39

Appendix 227

  • Abbreviations 227
  • Definitions 227
  • Research Methodology 228
  • Secondary Research 228
  • About GlobalData 229
  • Contact Us 229
  • Source 230
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.